tradingkey.logo
tradingkey.logo
Search

Silexion Therapeutics Corp - Phase 2/3 Trials To Start In First Half Of 2026

ReutersSep 4, 2025 3:05 PM
facebooktwitterlinkedin

- Silexion Therapeutics Corp SLXN.O:

  • SILEXION THERAPEUTICS ANNOUNCES SELECTION OF CONTRACT RESEARCH ORGANIZATION TO SUPPORT UPCOMING PHASE 2/3 CLINICAL TRIALS FOR SIL204

  • SILEXION THERAPEUTICS CORP - PHASE 2/3 TRIALS TO START IN FIRST HALF OF 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI